Abstract
In this chapter a summary is given of the most relevant epidemiological, etiological, diagnostic and therapeutic data regarding squamous cell carcinoma of the penis and the scrotum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J Urol. 2009;27(2):141–50.
Hernandez BY, Barnholtz-Sloan J, German RR, et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998–2003. Cancer. 2008;113(10 Suppl):2883–91.
Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol. 2004;5(4):240–7.
Stancik I, Holtl W. Penile cancer: review of the recent literature. Curr Opin Urol. 2003;13(6):467–72.
Dillner J, von Krogh G, Horenblas S, Meijer CJ. Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl. 2000;205:189–93.
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.
Ferreux E, Lont AP, Horenblas S, et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol. 2003;201(1):109–18.
Bezerra AL, Lopes A, Santiago GH, Ribeiro KC, Latorre MR, Villa LL. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer. 2001;91(12):2315–21.
Munger K. The role of human papillomaviruses in human cancers. Front Biosci. 2002;7:d641–9.
Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366(9490):991–8.
Harish K, Ravi R. The role of tobacco in penile carcinoma. Br J Urol. 1995;75(3):375–7.
Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control. 2001;12(3):267–77.
Horenblas S, von Krogh G, Cubilla AL, Dillner J, Meijer CJ, Hedlund PO. Squamous cell carcinoma of the penis: premalignant lesions. Scand J Urol Nephrol Suppl. 2000;205:187–8.
Dillner J, Meijer CJ, von Krogh G, Horenblas S. Epidemiology of human papillomavirus infection. Scand J Urol Nephrol Suppl. 2000;205:194–200.
von Krogh G, Horenblas S. Diagnosis and clinical presentation of premalignant lesions of the penis. Scand J Urol Nephrol Suppl. 2000;205:201–14.
Singh I, Khaitan A. Current trends in the management of carcinoma penis–a review. Int Urol Nephrol. 2003;35(2):215–25.
Kroon BK, Horenblas S, Nieweg OE. Contemporary management of penile squamous cell carcinoma. J Surg Oncol. 2005;89(1):43–50.
Sanchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol. 2005;173(6):1958–65.
Liegl B, Regauer S. Penile clear cell carcinoma: a report of 5 cases of a distinct entity. Am J Surg Pathol. 2004;28(11):1513–7.
Sobin LH, Wittekind C, International Union against Cancer. TNM classification of malignant tumours, vol. 6. Chichester/West Sussex/Hoboken: Wiley-Blackwell; 2002.
Broders AC. Squamous-cell epithelioma of the skin: a study of 256 cases. Ann Surg. 1921;73(2):141–60.
Horenblas S, van Tinteren H, Delemarre JF, Boon TA, Moonen LM, Lustig V. Squamous cell carcinoma of the penis. II. Treatment of the primary tumor. J Urol. 1992;147(6):1533–8.
Horenblas S, van Tinteren H, Delemarre JF, Moonen LM, Lustig V, van Waardenburg EW. Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes. J Urol. 1993;149(3):492–7.
Ornellas AA, Seixas AL, Marota A, Wisnescky A, Campos F, de Moraes JR. Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases. J Urol. 1994;151(5):1244–9.
Lopes A, Hidalgo GS, Kowalski LP, Torloni H, Rossi BM, Fonseca FP. Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy. J Urol. 1996;156(5):1637–42.
Pizzocaro G, Piva L, Bandieramonte G, Tana S. Up-to-date management of carcinoma of the penis. Eur Urol. 1997;32(1):5–15.
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: diagnosis of lymph node metastasis. BJU Int. 2001;88(5):467–72.
Horenblas S, Kroger R, Gallee MP, Newling DW, van Tinteren H. Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology. 1994;43(5):702–7.
Lont AP, Besnard AP, Gallee MP, van Tinteren H, Horenblas S. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 2003;91(6):493–5.
Scardino E, Villa G, Bonomo G, et al. Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology. 2004;63(6):1158–62.
Kroon BK, Horenblas S, Deurloo EE, Nieweg OE, Teertstra HJ. Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int. 2005;95(4):517–21.
Tabatabaei S, Harisinghani M, McDougal WS. Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer. J Urol. 2005;174(3):923–7; discussion 927.
Windahl T, Hellsten S. Laser treatment of localized squamous cell carcinoma of the penis. J Urol. 1995;154(3):1020–3.
Hadway P, Lynch M, Corbishley CM, Mortimer PS, Watkin NA. Squamous cell carcinoma of the penis in a patient with chronic isolated penile lymphoedema. Urol Int. 2006;76(1):87–8.
Sagerman RH, Yu WS, Chung CT, Puranik A. External-beam irradiation of carcinoma of the penis. Radiology. 1984;152(1):183–5.
Crook JM, Jezioranski J, Grimard L, Esche B, Pond G. Penile brachytherapy: results for 49 patients. Int J Radiat Oncol Biol Phys. 2005;62(2):460–7.
Solsona E, Iborra I, Rubio J, Casanova JL, Ricos JV, Calabuig C. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol. 2001;165(5):1506–9.
McDougal WS. Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion. J Urol. 1995;154(4):1364–6.
Horenblas S, Jansen L, Meinhardt W, Hoefnagel CA, de Jong D, Nieweg OE. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol. 2000;163(1):100–4.
Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol. 2003;170(3):783–6.
Horenblas S. Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int. 2001;88(5):473–83.
Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol. 2003;170(2 Pt 1):359–65.
Windahl T, Andersson SO. Combined laser treatment for penile carcinoma: results after long-term followup. J Urol. 2003;169(6):2118–21.
D’Ancona CA, Botega NJ, De Moraes C, Lavoura Jr NS, Santos JK, Rodrigues Netto Jr N. Quality of life after partial penectomy for penile carcinoma. Urology. 1997;50(4):593–6.
Opjordsmoen S, Fossa SD. Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol. 1994;74(5):652–7.
Horenblas S, van Tinteren H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumor, nodes and metastasis classification system. J Urol. 1994;151(5):1239–43.
Horenblas S, Newling DW. Local recurrent tumour after penis-conserving therapy. A plea for long-term follow-up. Br J Urol. 1993;72(6):976.
Lowe FC. Squamous-cell carcinoma of the scrotum. Urol Clin North Am. 1992;19(2):397–405.
Herr HW. Percivall Pott, the environment and cancer. BJU Int. 2011;108(4):479–81.
Southam AH, Wilson SR, Cancer of the Scrotum. The etiology, clinical features, and treatment of the disease. Br Med J. 1922;2(3229):971–970 971.
Dean AL. Epithelioma of scrotum. J Urol. 1948;60(3):508–18.
Lione JG, Denholm JS. Cancer of the scrotum in wax pressmen. II. Clinical observations. AMA Arch Ind Health. 1959;19(5):530–9.
Higgins CC, Warden JG. Cancer of the scrotum. J Urol. 1949;62(2):250–6.
Ray B, Whitmore Jr WF. Experience with carcinoma of the scrotum. J Urol. 1977;117(6):741–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Horenblas, S. (2015). Cancer Penis and Scrotum. In: Nargund, V., Raghavan, D., Sandler, H. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-0-85729-482-1_50
Download citation
DOI: https://doi.org/10.1007/978-0-85729-482-1_50
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-481-4
Online ISBN: 978-0-85729-482-1
eBook Packages: MedicineMedicine (R0)